Accumulus Synergy

Responsible Innovation

Next Generation Data and Information Exchange

We are a global nonprofit organization developing a communication and collaboration platform for the life science-regulatory ecosystem that aims to enhance the current methods of information and data exchange, ultimately benefiting patients around the globe.

A Regulatory-Centric Solution

Accumulus Synergy is creating a regulatory lifecycle solution, offering innovative technologies that aim to change industry ways of working. Our solution will strive to enable tremendous progress in the regulatory science space, particularly where there is the highest unmet medical need or public health opportunity.

An Information Superhighway

Accumulus Synergy is building an information superhighway that will help to facilitate standardization. Data from source to decision maker will facilitate real-time and efficient insight generation and global convergence toward single process, dataset, and submission.

Relevant to the Ecosystem

Accumulus Synergy is striving to be a convening hub, inclusive but not limited to pharmaceutical, biotechnology, generic, and medical device manufacturers, health authorities, and third-party solution developers.

News, Events & Publications

Accumulus Synergy Launches Highly Anticipated Cloud-Based Platform

Regulatory Authorities Around the World Engage as the Nonprofit Supports a Global Reliance Project  BURLINGAME, CA, February 8, 2024 – Accumulus Synergy, Inc. (“Accumulus”) is proud to announce that it has launched the initial version of its first-in-kind information and data exchange platform. “Today marks the beginning of a new era for the life sciences […]

Accumulus Synergy Responds Food and Drug Administration’s Information Technology Strategy

Biopharmaceutical companies push the boundaries of science to develop medicines, employ the most sophisticated techniques to visualize and analyze data, and then painstakingly transfer the results onto paper or PDFs to communicate data to regulators.

Walking the talk in digital transformation of regulatory review

Cloud-based regulatory platforms have the potential to substantially transform how regulatory submissions are developed, transmitted, and reviewed across the full life cycle of drug development. The benefits of cloud-based submission and review include accelerating critical therapies to patients in need globally and efficiency gains for both drug developers and regulators.